Introduction {#Sec1}
============

Active maternal smoking during pregnancy is a common and preventable specific adverse environmental exposure for the fetus \[[@CR1]--[@CR3]\]. Maternal smoking during pregnancy is associated with fetal growth retardation and increased risks of preterm birth and lower birth weight \[[@CR4]--[@CR6]\]. Maternal smoking during pregnancy also seems to increase the risk of obesity in the offspring \[[@CR7], [@CR8]\]. The mechanisms underlying these associations may include developmental adaptations leading to changes in body composition and appetite behaviour \[[@CR9], [@CR10]\]. A recent systematic review suggested that prenatal smoke exposure leads to a higher body mass index in childhood \[[@CR11]\]. However, using body mass index as outcome does not give information about body composition \[[@CR12], [@CR13]\]. Studies relating maternal smoking during pregnancy with direct measures of body composition in the offspring might be important since adverse body composition and especially unfavourable fat distribution are important contributors to metabolic syndrome outcomes \[[@CR14]\]. Thus far, studies on the association between maternal smoking during pregnancy and measures of body composition are scarce and showed inconsistent results \[[@CR15]--[@CR17]\]. Skinfold thickness is a valid and easy to perform measurement for subcutaneous fat mass assessment in young children in epidemiological studies \[[@CR12], [@CR13]\].

For the present study, we hypothesized that active maternal smoking during pregnancy leads to higher peripheral, central and total subcutaneous fat mass in young childhood. We examined in a population-based prospective cohort study among 907 Dutch mothers and children followed from early fetal life onwards, the associations of exposure to maternal smoking during pregnancy with peripheral, central and total subcutaneous fat mass at the ages of 1.5, 6 and 24 months.

Methods {#Sec2}
=======

Design {#Sec3}
------

This study was embedded in the Generation R Study, a population-based prospective cohort study of pregnant women and their children from fetal life onwards in Rotterdam, the Netherlands \[[@CR18], [@CR19]\]. Enrolment in the study was aimed at early pregnancy (gestational age \<18 weeks) but was possible until birth of the child. All children were born between April 2002 and January 2006, and form a prenatally enrolled birth-cohort that is currently followed until young adulthood. Of all eligible children in the study area, 61% were participating in the study at birth \[[@CR19]\]. Additional detailed assessments of fetal and postnatal growth and development were conducted in third trimester of pregnancy in a subgroup of 1,232 Dutch mothers and their children in order to exclude bias due to ethnicity \[[@CR19]\]. Dutch ethnicity was defined as having two parents and four grandparents born in the Netherlands \[[@CR19], [@CR20]\]. Pregnant mothers participating in the Generation R study, who met this criterion, were approached for the additional measurements \[[@CR18], [@CR19]\]. Of all approached women, 80% agreed to participate in the subgroup study. In total, 1,039 children participated in at least one of the postnatal assessments at the ages of 1.5, 6 and 24 months. The study protocol was approved by the Medical Ethical Committee of the Erasmus Medical Centre, Rotterdam. Written informed consent was obtained from all participants or their parents.

Data collection and measurements {#Sec4}
================================

Maternal smoking during pregnancy {#Sec5}
---------------------------------

Information about maternal smoking was obtained by postal questionnaires sent in first, second and third trimester of pregnancy. Response rates for these questionnaires were 91, 80, and 77%, respectively \[[@CR19]\]. Active maternal smoking at enrolment was assessed in the first questionnaire by asking the mother whether she smoked during her pregnancy. We grouped mothers into three categories: (1) never smoked; (2) smoked only until their pregnancy was acknowledged (first trimester only); and (3) continued to smoke during pregnancy. This first questionnaire was sent to all mothers, independently of gestational age at enrolment. In the second and third questionnaires, the mothers were asked whether they had smoked during the past 2 months (yes/no). Mothers who reported in the first questionnaire not to smoke or to have smoked until their pregnancy was acknowledged, but reported to have smoked in the second or third questionnaire were recategorized as ''continued smoking''. Among smokers, the number of cigarettes daily smoked was categorized into the categories: no smoking, \<5 cigarettes/day and \>5 cigarettes/day.

Subcutaneous fat mass measurements and anthropometrics {#Sec6}
------------------------------------------------------

Subcutaneous fat mass was measured as skinfold thickness (SFT) at the ages of 1.5, 6 and 24 months on the left side of the body at four different sites (biceps, triceps, suprailiacal and subscapular) according to standard procedures by using a skinfold calliper (Slim Guide, Creative Health Products) \[[@CR21]\]. Four well-trained medical assistants performed all measurements \[[@CR22]\]. The consensus between and among observers for the medical assistants was analysed using the intraclass correlation coefficient (ICC) \[[@CR23], [@CR24]\]. Intraobserver ICC was 0.88 and interobserver ICC was 0.76. Total subcutaneous fat mass was calculated from the sum of biceps SFT + triceps SFT + suprailiacal SFT + subscapular SFT. Central subcutaneous fat mass was calculated from the sum of suprailiacal SFT + subscapular SFT. Peripheral subcutaneous fat mass was calculated from the sum of biceps SFT + triceps SFT \[[@CR25], [@CR26]\]. Body length was measured in supine position to the nearest millimeter using a neonatometer and at the age of 24 months, height was measured by a Harpenden stadiometer (Holtain Limited, Dyfed, UK) in standing position. Weight was measured in naked infants to the nearest grams at the ages of 1.5 and 6 months by an electronic infant scale (SECA) and at the age of 24 months by a mechanical personal scale (SECA).

Covariates {#Sec7}
----------

Birth weight, date of birth and sex were obtained from midwife and hospital registries at birth. Information about highest attained maternal educational level (low, moderate and higher), and parity (primipara, multipara) were obtained at enrolment in the study \[[@CR27]\]. Educational level of the mother was defined according to the classification of Statistics Netherlands \[[@CR28]\]. Maternal height and weight were assessed at enrolment. Height and weight were measured while the mother stood without shoes and without heavy clothing. Body mass index was calculated (kg/m^2^). Information on breastfeeding (yes/no) was obtained by postnatal questionnaires at the ages of 2, 6, and 12 months. Mothers were asked whether they ever breastfed their child (yes/no) and at what age they quitted breastfeeding.

Population for analysis {#Sec8}
-----------------------

From the total of 1,106 children and their mothers who gave consent for participating in the postnatal phase, 1,039 children participated in at least one of the postnatal assessments at the ages of 1.5, 6 and 24 months (Fig. [1](#Fig1){ref-type="fig"}). Children without complete information on maternal smoking during pregnancy (n = 111) were excluded from the analyses. Of the remaining 928 live births with complete data on maternal smoking, information about the sum of skinfold thickness measurements in at least one of the three visits was available in 907 children. Twins (n = 24) were not excluded from the analyses, as they did not differ in the outcome measure from the singletons and no differences in results were observed after excluding them. Missing skinfold measurements were mainly due to crying behaviour. Percentage of maternal smoking was not different between participating mothers (n = 907) and those lost to follow-up (n = 325).Fig. 1Flow chart of participants in study

Statistical analysis {#Sec9}
--------------------

Differences in baseline characteristics between the maternal smoking categories were compared with Student's *t* test for continuous variables and Chi-square tests for categorical variables. Similarly, we tested the differences in peripheral, central and total subcutaneous fat mass between the maternal smoking categories at the ages of 1.5, 6 and 24 months. The associations between period of maternal smoking during pregnancy (no, first trimester only, continued) and peripheral, central and total subcutaneous fat mass at the ages of 1.5, 6 and 24 months, were assessed using multiple linear regression models. The models were adjusted for potential confounders including child's age at visit, sex, maternal education, maternal height and weight, breastfeeding (yes/no), current height and observer of the skinfold measurement. Postnatal smoking, birth weight, parity, maternal alcohol use and maternal age were not included in the final models since they did not materially change the effect estimates. Similar regression models were used for assessing the associations of the reported number of cigarettes smoked in both first and third trimester of pregnancy and peripheral, central, and total subcutaneous fat mass. The associations between period of maternal smoking during pregnancy and anthropometrics like height, weight and body mass index at the ages of 1.5, 6 and 24 months, were also assessed using multiple linear regression models. These models were adjusted for potential confounders like age at visit, sex, maternal education, maternal height and weight, and breastfeeding (yes/no).

Tests for trends were performed by treating each categorized variable as a continuous term and by entering the variable into the fully adjusted linear regression model. To handle missing values in covariates (\<20% missing), we performed multiple imputations with a software package by generating 5 independent datasets for all analyses. Imputations were based on the relationships between all covariates included in this study using the Markov Chain Monte Carlo method. All measures of association are presented with their 95% CI. Statistical analyses including the multiple imputations were performed using the Statistical Package of Social Sciences version 17.0 for Windows (SPSS Inc., Chicago, IL, USA).

Results {#Sec10}
=======

Of all mothers included in the analyses, 9.2% (n = 83) reported smoking in first trimester only and 13.8% (n = 125) reported continued smoking during pregnancy (Table [1](#Tab1){ref-type="table"}). Mothers who continued smoking were younger and lower educated than mothers who never smoked during pregnancy. Mean birth weights of children from mothers who never smoked during pregnancy and who continued smoking were 3,533 grams (SD 545) and 3,267 grams (SD 573), respectively. In children of mothers who continued smoking, the highest rate for small size for gestational age (14.4%) and lowest rate for ever breastfeeding (82.5%) were observed. As compared to mothers who did participate, those who did not participate were younger (*P* \< 0.01). Furthermore, they had a lower educational level and were more likely to smoke (*P* \< 0.01). Their children were also born more frequently preterm and with a lower birth weight (*P* \< 0.05) (data not shown).Table 1Characteristics of mothers and their children according to category of maternal smoking during pregnancyN = 907No smoking (n = 699, 77.1%)Smoked in first trimester only (n = 83, 9.2%)Continued smoking (n = 125, 13.8%)Maternal characteristicsAge (years)31.9 (25.3--37.8)31.2 (22.1--38.4)30.8 (21.5--38.0)\*\*Height (cm)171.3 (6.4)171.2 (6.6)169.5 (6.2)\*\*Weight (kg)71.7 (13.3)69.7 (11.3)71.1 (13.5)Body mass index (kg/m^2^)24.4 (4.3)23.7 (3.4)24.7 (4.5)Highest completed education (%) Primary school1.04.96.4\*\* Secondary school30.734.957.6\*\* Higher education68.360.236.0\*\*Alcohol consumption in pregnancy (%) Ever69.085.5\*\*68.0 Never31.014.5\*\*31.0Parity (%) 060.971.157.6 \>=139.128.942.4Birth Males (%)514658\* Gestational age (weeks)40.0 (37.0--42.1)39.7 (33.9--42.0)39.8 (35.7--42.1) Weight (grams)3,533 (545)3,458 (659)3,267 (573)\*\* Small for gestational age (\<5%)3.13.614.4\*\* Low birth weight (\<2,500 g) %3.98.47.2 Preterm birth (%)5.29.66.4Breastfeeding Ever (%)90.694.082.5\*\* Duration (months)5.4 (0.5--12.0)4.6 (0.5--12.0)2.5 (0.5--8.5)\*\*Values are means (SD), percentages or medians (90% range) for variables with skewed distributionDifferences in maternal and child characteristics (compared with the nonsmoking category) were evaluated using Students *t* test for continuous variables and chi-squared tests for categorical variables. Gestational age was log-transformed for the *t* test. Birth weight in SDS was used for the *t* testSmall for gestational age is defined as the lowest 5% of gestational age adjusted birth weight\* *P* \< 0.05 and \*\* *P* \< 0.01

Table [2](#Tab2){ref-type="table"} shows that we observed no differences in the unadjusted peripheral, central and total subcutaneous fat mass measurements during childhood between the offspring of non-smoking mothers, mothers who smoked in first trimester and mothers who continued smoking. Table [3](#Tab3){ref-type="table"} gives the associations between period of maternal smoking, and the number of cigarettes smoked per day among mothers who smoked in first trimester only and those who continued smoking with peripheral, central and total subcutaneous fat mass at the ages of 1.5, 6 and 24 months. Smoking in first trimester only and continued smoking were not significantly associated with subcutaneous fat mass at any age. Offspring of mothers who continued to smoke more than 5 cigarettes per day tended to have higher peripheral, central and total subcutaneous fat mass at the age of 24 months (P for trend \>0.05). However, it is likely a chance finding given it didn't seem to be an a priori association from the methods and multiple comparisons. Table [4](#Tab4){ref-type="table"} shows the associations between period of maternal smoking, and the number of cigarettes smoked per day among mothers who smoked in first trimester only and those who continued smoking with height, weight and body mass index at the ages of 1.5, 6 and 24 months. Children of mothers who continued smoking tended to have a lower height and weight at all ages compared to non-smoking mothers. Offspring of mothers who smoked more than 5 cigarettes per day among those who smoked in first trimester only and those who continued smoking, tended to have a lower height and weight (*P* for trend \<0.10). The association with body mass index at these ages seems not to be consistent, but tends to a negative relation with anthropometrics.Table 2Subcutaneous fat mass measurements according to maternal smoking during pregnancy categoryN = 907No smoking (n = 699, 77.1%)Smoked in first trimester only (n = 83, 9.2%)Continued smoking (n = 125, 13.8%)1.5 months (n = 758) Age (months)1.60 (1.12--2.47)1.59 (1.08--2.49)1.63 (1.03--2.66) Triceps (mm)6.6 (4.0--12.0)6.5 (4.0--12.0)6.6 (3.5--12.0) Biceps (mm)5.5 (3.0--11.0)5.5 (3.0--10.0)5.6 (3.0--10.0) Suprailiacal (mm)5.8 (3.0--10.0)5.8 (3.0--10.4)5.7 (3.0--9.9) Subscapular (mm)6.2 (4.0--9.6)6.3 (4.0--10.0)6.1 (3.0--9.0) Peripheral fat mass (mm)12.2 (7.0--22.2)12.0 (7.0--22.3)12.2 (7.0--21.0) Central fat mass (mm)12.0 (7.0--19.0)12.1 (7.8--20.0)11.8 (7.0--19.0) Total fat mass (mm)24.2 (15.0--39.9)24.1 (15.5--41.4)24.0 (14.0--40.5)6 months (n = 791) Age (months)6.49 (5.61--7.88)6.52 (5.70--7.84)6.48 (5.46--7.91) Triceps (mm)7.9 (5.0--13.0)8.1 (4.7--14.0)7.8 (5.0--11.4) Biceps (mm)6.5 (4.0--11.0)6.9 (4.0--11.3)6.6 (4.0--10.0) Suprailiacal (mm)6.3 (3.5--10.0)6.7 (3.5--9.3)6.1 (3.1--9.8) Subscapular (mm)6.3 (4.0--9.0)6.6 (4.0--9.6)6.3 (4.0--9.0) Peripheral fat mass (mm)14.5 (9.0--22.0)14.9 (9.0--25.3)14.4 (9.1--21.0) Central fat mass (mm)12.6 (8.0--19.0)13.3 (8.0--19.0)12.4 (7.6--18.0) Total fat mass (mm)27.1 (19.0--39.0)28.2 (17.0--43.3)26.8 (17.1--37.4)24 months (n = 658) Age (months)25.29 (23.79--27.61)25.45 (23.92--29.16)25.51 (23.95--28.04) Triceps (mm)8.8 (5.0--14.0)8.7 (4.0--13.3)9.0 (5.0--13.9) Biceps (mm)6.7 (4.0--11.0)6.6 (3.4--11.7)6.9 (4.0--11.0) Suprailiacal (mm)5.6 (3.0--9.0)5.8 (3.0--11.3)5.7 (3.0--9.0) Subscapular (mm)6.0 (3.5--9.0)6.2 (4.0--10.0)6.3 (4.0--9.8) Peripheral fat mass (mm)15.5 (9.0--24.0)15.3 (9.0--24.8)15.8 (9.6--24.0) Central fat mass (mm)11.6 (7.0--18.0)12.0 (7.2--18.7)12.0 (7.0--18.0) Total fat mass (mm)27.1 (17.5--40.0)27.3 (18.0--44.2)28.0 (18.0--41.1)Values are medians (90% range). Differences in child characteristics (compared with the non-smoking category) were evaluated using Students *t* test for continuous variablesPeripheral subcutaneous fat mass was calculated from the sum of biceps SFT + triceps SFT. Central subcutaneous fat mass was calculated from the sum of suprailiacal SFT + subscapular SFT. Total subcutaneous fat mass was calculated from the sum of biceps SFT + triceps SFT + suprailiacal SFT + subscapular SFTTable 3Associations of maternal smoking during pregnancy with subcutaneous fat measures in children aged 1.5, 6 and 24 months1.5 months6 months24 monthsPeripheral fat (mm)Central fat (mm)Total fat (mm)Peripheral fat (mm)Central fat (mm)Total fat (mm)Peripheral fat (mm)Central fat (mm)Total fat (mm)Maternal smokingN = 781N = 759N = 759N = 794N = 792N = 803N = 672N = 660N = 659No (n = 699)ReferenceReferenceReferenceReferenceReferenceReferenceReferenceReferenceReferenceFirst trimester only (n = 83)−0.30 (−1.30, 0.70)−0.02 (−0.90, 0.86)−0.32 (−2.09, 1.45)0.61 (−0.35, 1.56)0.62 (−0.19, 1.43)1.22 (−0.35, 2.79)0.07 (−1.08, 1.23)0.40 (−0.52,1.32)0.47 (−1.36, 2.30)\<5 cigarettes/day (n = 53)−1.06 (−2.27, 0.15)−0.27 (−1.32, 0.79)−1.29 (−3.41, 0.83)0.29 (−0.89, 1.46)0.50 (−0.50, 1.50)0.78 (−1.16, 2.71)0.63 (−0.76, 2.01)0.85 (−0.26,1.96)1.48 (−0.71, 3.68)\>5 cigarettes/day (n = 30)1.10 (-0.50, 2.70)0.45 (-0.97, 1.87)1.52 (−1.34, 4.38)1.17 (−0.38, 2.72)0.81 (−0.52, 2.14)1.96 (−0.62, 4.53)−0.95 (−2.90, 0.99)−0.41(−1.97,1.15)−1.39 (−4.47, 1.69)*P for trendP* = 0.82*P* = 0.80*P* = 0.82*P* = 0.15*P* = 0.14*P* = 0.10*P* = 0.77*P* = 0.69*P* = 0.99Continued (n = 125)0.13 (−0.78, 1.03)0.07 (−0.73, 0.87)0.23 (−1.38, 1.84)0.02 (−0.82, 0.87)−0.28 (−0.99, 0.44)−0.26 (−1.65, 1.12)0.54 (−0.55, 1.63)0.44 (−0.44,1.31)1.03 (−0.72, 2.78)\<5 cigarettes/day (n = 51)−0.10 (−1.42, 1.22)−0.41 (−1.57, 0.75)−0.47 (−2.81, 1.87)−0.01 (−1.23, 1.20)−0.30 (−1.32, 0.73)−0.32 (−2.31, 1.67)−1.04 (−2.64, 0.56)−0.89 (−2.21, 0.43)−1.85 (−4.45, 0.76)\>5 cigarettes/day (n = 53)0.15 (−1.12, 1.41)0.04 (−1.06, 1.14)0.22 (−2.01, 2.44)−0.22 (−1.44, 0.99)−0.54 (−1.57, 0.49)−0.77 (−2.77, 1.23)1.46 (−0.08, 3.01)1.21(−0.04, 2.46)2.67 (0.20, 5.14)\**P for trendP* = 0.88*P* = 0.86*P* = 0.97*P* = 0.75*P* = 0.26*P* = 0.43*P* = 0.24*P* = 0.23*P* = 0.17Values are regression coefficients (95% confidence interval) using multiple linear regression modelsModels are adjusted for child's age at visit, sex, maternal education, maternal height and weight, breastfeeding ever, current height and observerPeripheral subcutaneous fat mass was calculated from the sum of biceps SFT + triceps SFT. Central subcutaneous fat mass was calculated from the sum of suprailiacal SFT + subscapular SFT. Total subcutaneous fat mass was calculated from the sum of biceps SFT + triceps SFT + suprailiacal SFT + subscapular SFT\* *P* \< 0.05Table 4Associations of maternal smoking during pregnancy with anthropometrics in children aged 1.5, 6 and 24 months1.5 months6 months24 monthsHeight (cm)Weight (g)Body Mass Index (kg/m^2^)Height (cm)Weight (g)Body Mass Index (kg/m^2^)Height (cm)Weight (g)Body Mass Index (kg/m^2^)Maternal smokingN = 765N = 767N = 765N = 774N = 776N = 774N = 671N = 692N = 671No (n = 699)ReferenceReferenceReferenceReferenceReferenceReferenceReferenceReferenceReferenceFirst trimester only (n = 83)−0.51 (−1.06, 0.03)−5 (−152, 142)0.22 (−0.13, 0.56)−0.24 (−0.80, 0.33)107 (−87, 300)0.35 (0.03, 0.67)\*0.14 (−0.60, 0.88)12 (−310, 334)−0.11 (−0.44, 0.21)\<5 cigarettes/day (n = 53)−0.62 (−1.11, −0.13)\*−101 (−235, 32)0.01 (−0.30, 0.32)−0.20 (−0.70, 0.30)18 (−158, 194)0.14 (−0.16, 0.43)−0.19 (−0.88, 0.50)−42 (−343, 258)−0.05 (−0.35, 0.25)\>5 cigarettes/day (n = 30)−0.90 (−1.46, −0.34)\*\*−200 (−353, −46)\*−0.19 (−0.55, 0.17)−0.63 (−1.18, −0.07)\*−52 (−246, 142)−0.19 (−0.13, 0.52)−0.42 (−1.19, 0.34)−208 (−544, 127)−0.15 (−0.49, 0.19)*P for trendP* \< 0.01*P* \< 0.01*P* = 0.38*P* = 0.03*P* = 0.71*P* = 0.17*P* = 0.25*P* = 0.24*P* = 0.38Continued (n = 125)−0.96 (−1.46, −0.47)\*\*−268 (−402, −134)\*\*−0.33 (−0.64, −0.01)\*−0.45 (−0.94, 0.05)−103 (−274, 68)−0.01 (−0.29, 0.28)−0.69 (−1.38, 0)−263 (−567,42)−0.11 (−0.42, 0.19)\<5 cigarettes/day (n = 51)−1.02 (−1.75, −0.30)\*\*−264 (−461, −67)\*\*−0.27 (−0.73, 0.19)−0.41 (−1.12, 0.31)−144 (−390, 102)−0.10 (−0.51, 0.30)−0.88 (−1.91, 0.16)−524 (−974, −73)\*−0.44 (−0.89, 0.01)\>5 cigarettes/day (n = 53)−1.14 (−1.83, −0.45)\*\*−363 (−550, −175)\*\*−0.53 (−0.97, −0.09)\*−0.54 (−1.24, 0.17)−189 (−431, 53)−0.14 (−0.54, 0.27)−0.80 (−1.75, 0.16)−229 (−653, 194)0.02 (−0.40, 0.45)*P for trendP* \< 0.01*P* \< 0.01*P* = 0.01*P* = 0.08*P* = 0.07*P* = 0.43*P* = 0.04*P* = 0.07*P* = 0.54Values are regression coefficients (95% confidence interval) using multiple linear regression modelsModels are adjusted for child's age at visit, sex, maternal education, maternal height and weight, breastfeeding ever\* *P* \< 0.05 and \*\* *P* \< 0.01

Discussion {#Sec11}
==========

Main findings {#Sec12}
-------------

This population-based prospective cohort study showed that maternal smoking in first trimester only and continued smoking during pregnancy were not associated with peripheral, central and total subcutaneous fat mass at the ages of 1.5, 6 and 24 months.

Strengths and weaknesses {#Sec13}
------------------------

Major strengths of this study are the population-based prospective design with subjects being studied from early pregnancy onwards, and information about a large number of potential confounders available. However, some methodological issues need to be considered. Of the 1,039 children of this study who participated postnatally, information about smoking during pregnancy at enrolment was missing in 11% of all mothers. This non-response would lead to biased effect estimates if the associations of maternal smoking during pregnancy with skinfold measurements in early childhood would be different between those included and not included in the analyses. However, this seems unlikely because biased estimates in cohort studies mainly arise from loss to follow-up rather than from non-response at baseline \[[@CR29], [@CR30]\]. The percentage of mothers who smoked during pregnancy may have been higher among those not included in the present analyses than among those who were included. This might have led to loss of statistical power and some under-estimation of the estimated effects. Of the postnatal participants, skinfold thickness measurements were performed in at least 80%. Missing skinfold measurements were mainly due to crying behaviour. Information about maternal smoking during pregnancy was collected by questionnaires, without reference to any skinfold measurement. Although assessing smoking during pregnancy by questionnaire seems to be a valid method, misclassification may occur \[[@CR31]\]. Underreporting of maternal smoking across the various smoking categories may be present and have led to misclassification. In general, underreporting would lead to underestimation of differences between children from smoking and non-smoking mothers. Also, our study group was ethnic homogeneous and the mothers were highly educated. This may limit the generalizability of our results \[[@CR30]\]. Finally, we used skinfold thickness as a measure of subcutaneous fat mass. Skinfold thickness provides a simple, easy, and quick yet highly informative assessment of regional fatness in most age groups and can be used in large-scale epidemiological studies, but has a limitation in differentiating between lean and fat mass of the whole body \[[@CR12]\].

Comparison of main findings with other studies {#Sec14}
----------------------------------------------

Obesity in both childhood and adulthood lead to different risk factors for cardiovascular diseases, diabetes type II and overall mortality \[[@CR32]--[@CR43]\].

Various studies suggest that exposure to maternal smoking during fetal life leads to overweight and obesity in childhood. A systematic review by Oken suggested that prenatal maternal smoking exposure leads to a 50% increased risk of overweight in childhood at the ages of 3-33 years \[[@CR11]\]. Also, a recent meta-analysis using 17 studies showed that maternal smoking during pregnancy was consistently associated with obesity in children with a mean age of 9 years \[[@CR8]\]. It has been suggested that there is a dose-response association between the number of smoked cigarettes and the risk of childhood obesity \[[@CR44]\]. These studies used body mass index as measure for childhood obesity. Using body mass index does not provide information about fat distribution \[[@CR12]\]. A limited number of studies focused on the associations of maternal smoking during pregnancy with direct measures of body composition instead of body mass index. A study in Southampton showed in 448 neonates that maternal smoking in late pregnancy was weakly associated with a lower fat mass percentage and greater lean mass percentage \[[@CR45]\]. Another study in Sweden and Norway observed in 315 children aged 5 years that maternal smoking was associated with an increased risk of skinfold thickness higher than the 85th percentile, however the associations attenuated after adjustment for confounders like total energy intake of the parents \[[@CR17]\]. In contrast, a study in Boston, among 746 children at the age of 3 years, showed no association of maternal smoking during pregnancy with central adiposity, measured by the subscapular and triceps ratio, which has been found to be a valid proxy for intra-abdominal adipose tissue among children \[[@CR15]\].

A study in Bristol, the United Kingdom found in 5,689 children with mean age of 10 years that maternal smoking at any time during pregnancy is associated with higher offspring total fat mass measured with Dual X-ray Absorptiometry (DXA). Maternal smoking was also associated with higher lean mass, but to a lesser extent \[[@CR16]\]. In our study, we used skinfold thickness as measure of subcutaneous fat mass at the ages of 1.5, 6 and 24 months. We did not find significant associations between maternal smoking during pregnancy and peripheral, central and total subcutaneous fat mass in early childhood. We also did not observe associations between the number of cigarettes smoked during pregnancy and peripheral, central and total subcutaneous fat mass in the offspring. Most previous studies assessed the associations between maternal smoking and adiposity at older age. The lack of association in this study might be due to the younger age groups, or use less advanced measuring techniques. This might also be the explanation for the inconsistent associations between maternal smoking during pregnancy and body mass index. In the future, genome wide association studies might identify new genetic loci related to skinfold thickness \[[@CR46]\].

Studies examining the influence of prenatal smoke exposure in different periods of pregnancy might identify critical time periods, which are important from both a developmental and preventive perspective. We showed that both maternal first trimester smoking and continued smoking were not associated with peripheral, central and total subcutaneous fat mass until the age of 2 years.

Conclusion {#Sec15}
==========

Our findings suggest that intrauterine exposure to maternal cigarette smoke in different periods during pregnancy does not influence peripheral, central and total subcutaneous fat mass development in early childhood. Further studies are needed in children at older ages and to identify associations of maternal smoking during pregnancy with other measures of body composition like DXA and Magnetic Resonance Imaging.
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